Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,761.00
Bid: 1,757.50
Ask: 1,758.00
Change: 27.50 (1.59%)
Spread: 0.50 (0.028%)
Open: 1,736.00
High: 1,767.00
Low: 1,736.00
Prev. Close: 1,733.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

MARKET COMMENT: UK Stocks Up, While Pound Retreats On BoE Minutes

Wed, 23rd Jul 2014 09:53

LONDON (Alliance News) - UK stocks are trading modestly higher Wednesday, while the pound has slipped from early highs after minutes from the latest Bank of England Policy meeting sounded a little less hawkish about the UK economy than expected.

By mid-morning Wednesday, the FTSE 100 is up 0.2% at 6,812.53, the FTSE 250 is up 0.3% at 15,699.05, while the AIM All-Share is up 0.1% at 773.48.

Major European markets are showing even more positivity in light of the decision by EU officials on Tuesday not to impose sector-wide, or "tier-three", sanctions on the Russian economy. By mid-morning, the German DAX and the French CAC are both up 0.5%.

The Monetary Policy Committee of the Bank of England voted 9-0 to keep the UK base rate unchanged at 0.5%, and also to maintain the central bank's stocks of purchased assets at GBP375 billion, according to the minutes of the July 9 and 10 MPC meeting released Wednesday.

The results of the vote came as little surprise to most, but the pound did fall a little from its morning highs against both the dollar and the euro, as there had been an expectation from some quarters that one or more of the MPC members would have seen fit to vote for a rate rise, given the apparent strength of the UK economic recovery. Against the dollar, the pound fell from USD1.7095 to a session low of USD1.7026, and against the euro, sterling fell to EUR1.2645 from an earlier two-year high of EUR1.2696.

The minutes broadly maintained a balanced perspective of the UK economy and the potential for the first interest rate rise, noting that "sustained economic momentum was looking more assured," but also that "it remained unclear whether growth would slow modestly in the second half of the year, as envisaged in the May Inflation Report."

Slack wage growth remains the primary concern of the committee, and the key measure to watch for those trying to gauge when interest rates will rise. The committee noted two possible reasons for the current disappointing wage growth: either that the lag between falling unemployment and higher wages is longer than previously judged, or that people are working longer hours for the same pay, or the same hours for less pay, than before.

"Such decisions might have been prompted by a number of factors, including concerns about the adequacy of retirement provisions, changes to benefits, or the weakness of current levels of income," the minutes say.

While the MPC minutes have shown the central bank's historical opinion on the economy, Governor Mark Carney might give a more up-to-date view at 1245 BST, when he delivers a speech to the Commonwealth Games Trade and Investment Conference in Glasgow. Given Carney's recent changes in tone and market-moving comments, his words will be monitored closely.

Released at the same time as the minutes, the British Bankers Association said it approved 43,300 mortgages in June, which is up a little from the 41,800 it approved in May and just fractionally below the expectation of 43,400.

Within UK equity movers, Renishaw is the stand-out gainer, having shot to the top of the FTSE 250 at the opening bell. The UK engineering group reported an increase in profit for its recent full year to GBP96.4 million from GBP82.1 million a year earlier. Of the bumper profit, GBP26.3 million came from the disposal of the group's 19.4% stake in previously AIM-listed Delcam, while Renishaw also said that its metrology, or industrial measurement business, saw strong demand. The shares are trading almost 15% higher, helping the FTSE 250 index outperform the FTSE100.

Capita leads the gainers in the blue-chip index, up 4.1% after raising its interim dividend by 10% in an expression of confidence of meeting its full year targets. The outsourcing company posted a pretax profit of GBP152.3 million, down from GBP157.5 million in the previous year, while revenue rose to GBP2.07 billion from GBP1.82 billion. Liberum Capital says the results are slightly ahead of its expectations, and that with a bid pipeline of GBP5.7 billion, Capita is enjoying a period of "strong win momentum".

BHP Billiton is up 1.2% after reporting a 20% increase in annual iron ore production over the 2014 full-year, marking its fourteenth consecutive annual production record.

Energy supplier SSE leads the FTSE 100 fallers, down 3.1% after going ex a GBP0.607 pence full-year dividend.

Johnson Matthey is down 1.4% after saying that its pretax profit fell by 10% during the quarter to June 30, coming in at GBP95.0 million, compared to the GBP106.09 million recorded in 2013.

Still to come Wednesday, GlaxoSmithKline is due to release second quarter results at midday, before attention switches back to the overall economy when Carney talks in Glasgow at 1245 BST.

US MBA weekly mortgage applications data is due at 1200 BST, followed by the eurozone consumer confidence index at 1500 BST, which is expected to remain unchanged in July at negative 7.5.

It's also the busiest day of US second quarter earnings releases so far, with a raft of names from American Airlines to Starbucks to Facebook slated to report.

Futures trading currently indicates that US stocks will open fractionally higher, with the DJIA and the S&P 500 both up by less that 0.1%.

By Jon Darby; jondarby@alliancenews.com; @jondarby100

Copyright 2014 Alliance News Limited. All Rights Reserved.

More News
Today 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

Read more
2 May 2024 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.

Read more
2 May 2024 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 22:39

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.